Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phosphodiesterase 7 (PDE7) is a member of the phosphodiesterase superfamily that specifically hydrolyzes cyclic adenosine monophosphate (cAMP), playing a crucial role in regulating intracellular cAMP signaling pathways. It exists as two main isoforms, PDE7A and PDE7B, with various splice variants. PDE7 is predominantly found in the central nervous system (CNS) and immune cells. By regulating cAMP levels, PDE7 impacts T cell activation, neurogenesis, synaptogenesis, and memory formation. Increased expression or activity of PDE7 has been implicated in several diseases, including Parkinson’s disease, Alzheimer’s disease, multiple sclerosis and various cancers, making it an attractive drug target, particularly for CNS disorders and inflammatory diseases. Common inhibitors include IBMX and papaverine, but isozyme-selective inhibitors are under development.
Inhibition of cAMP hydrolysis
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphodiesterase 7 (PDE7).